AARP Applauds CMS’ Final Guidance for Medicare Negotiation Implementation to Lower Drug Prices
Post Content
AARP Responds to 2023 Social Security and Medicare Trustees’ Reports
Post Content
AARP Responds to 2023 State of the Union Address
Post Content
AARP CEO Statement on Protecting Social Security and Medicare
Post Content
AARP Statement on Senate Passage of Bipartisan, Omnibus Bill
Post Content
AARP Pleased with Decrease in Medicare Part B Premiums and Deductibles for 2023
Lower Premiums and Deductibles Will Help Seniors with Rising Costs Due to Inflation
AARP: Inflation Reduction Act Brings Prescription Drug Price Relief for Our Members and All Older Americans
New Law Will Lower Prescription Drug Prices for Seniors and Limit Medicare Plan Out-of-Pocket Costs
AARP Statement on New CMS Proposal to Require Minimum Nursing Home Staffing Levels
Post Content
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation
Post Content
New Report: Top Medicare Part D Drugs Have More Than Tripled in Price Since Entering Market
Post Content